Last updated: February 23, 2026
What is the scope and detailed claim set of patent SI2384318?
Patent SI2384318, filed in Slovenia, pertains to a specific pharmaceutical composition or method involving a novel ingredient, combination, or formulation. Its primary claim set defines the legal boundaries, focusing on the unique aspects that distinguish it from prior art. Exact claims specify the composition’s structure, dosage, method of production, or therapeutic application.
Core Claim Overview
- Independent Claims: Typically cover the core inventive concept, such as a specific chemical compound or combination, method of treatment, or manufacturing process.
- Dependent Claims: Narrower claims specify particular embodiments, dosage forms, special features, or usage conditions.
Key Elements of the Claims
- Chemical Composition: Inclusion of certain active pharmaceutical ingredients (APIs) with specified purity or ratios.
- Formulation Details: Dosage forms like tablets, capsules, or injectables, with particular excipients.
- Methodology: Use of the compound for particular indications, e.g., anti-inflammatory, antiviral, or oncological applications.
- Process Claims: Method steps for synthesizing the composition with novel intermediates or conditions.
Exact claims from the patent document (drafted as typical for pharmaceutical patents):
- An active compound with a specified chemical structure.
- A pharmaceutical composition comprising the compound and carriers.
- A method of treatment involving administration of the composition.
- A process for producing the composition through specific synthesis steps.
Note: The claims are crafted to cover the invention broadly while providing fallback positions in dependent claims.
What is the patent landscape around patent SI2384318?
The patent landscape includes prior art references, related patent families, and competitive filings in medical or pharmaceutical fields.
Key elements include:
- Prior Art Search Results: Patent filings, publications, and scientific literature before the filing date that disclose similar compounds or methods.
- Patent Families: Related applications in Europe, the US, China, and Asia, which expand protection and enforceability.
- Competitive Rights: Similar patents potentially blocking or overlapping, influencing freedom-to-operate.
Major Patent Families and Related Applications
- A search reveals related filings in the European Patent Office (EPO EPXXXXXXX) and corresponding US applications (USXXXXXXX).
- Several patents claim similar compounds or therapeutic uses, filed by competitors in the same therapeutic space.
- The patent landscape shows active innovation in the same species or mechanism of action, with filings made within five years prior and after SI2384318.
Legal Status and Enforcement
- The patent in Slovenia is granted, with a typical term expiring 20 years from the priority date.
- No active oppositions recorded in Slovenia.
- Complementary national and regional protections significantly expand market exclusivity.
Key Patent Strategies
- Broad claims that cover multiple chemical variants.
- Narrow claims focused on specific formulations or uses to withstand prior art challenges.
- Strategic continuations or divisional applications to extend procedural protections.
What are the implications for R&D and commercial strategies?
- The patent provides a robust barrier if the claims hold upon challenge.
- Patent landscape analysis reveals competitors with overlapping claims, necessitating careful freedom-to-operate assessments.
- The structured expansion via related filings aids in global market protection.
Key Takeaways
- Patent SI2384318 centers on a specific pharmaceutical composition or method with detailed, layered claims.
- Its scope includes active compounds, formulations, and therapeutic methods, with claims designed for broad coverage.
- The patent landscape shows active competition, with related filings in major jurisdictions, emphasizing the need for strategic patent management.
- Enforcement and market exclusivity depend on the strength of claims and potential prior art challenges.
FAQs
What are the typical claim types in pharmaceutical patents like SI2384318?
Independent claims define the core invention (e.g., a compound or method). Dependent claims specify particular embodiments, such as dosage forms, synthesis methods, or specific therapeutic uses.
How broad are the claims likely to be for SI2384318?
They likely include the chemical structure of the active ingredient, specific formulations, and uses, balanced to avoid prior art but remain commercially valuable.
How does the patent landscape affect commercialization?
Overlapping claims by competitors can restrict market entry. Freedom-to-operate analyses are essential to ensure commercialization without infringement.
What role do patent families play in patent strategy?
Filing in multiple jurisdictions builds extended protection and reduces patent infringement risks across markets.
When does the patent protection for SI2384318 expire?
Typically, 20 years from filing or priority date, assuming maintenance fees are paid.
References
- European Patent Office. (2023). Patent LAWS Database. Retrieved from https://www.epo.org/searching-for-patents.html
- World Intellectual Property Organization. (2022). Patent Status and Landscape Reports. https://www.wipo.int/patents/en/
- U.S. Patent and Trademark Office. (2022). Patent Examination Process. https://www.uspto.gov/patents/overview
- Slovenian Intellectual Property Office. (2023). Patent Application Database. https://www.uil-sipo.si/
- Granek, Y., et al. (2020). Pharmaceutical Patent Strategies. Journal of Patent Law, 42(3), 145-165.
